P573-1635 Screening compound: methyl 4-{2-[7-(3-methylpiperidin-1-yl)-3-oxo-2H,3H-[1,2,4]triazolo[4,3-a]pyrimidin-2-yl]acetamido}benzoate

P573-1635 Screening compound: methyl 4-{2-[7-(3-methylpiperidin-1-yl)-3-oxo-2H,3H-[1,2,4]triazolo[4,3-a]pyrimidin-2-yl]acetamido}benzoate
P573-1635 Screening compound: methyl 4-{2-[7-(3-methylpiperidin-1-yl)-3-oxo-2H,3H-[1,2,4]triazolo[4,3-a]pyrimidin-2-yl]acetamido}benzoate alternative view

Chemical Structure Depiction of ChemDiv screening compound P573-1635
methyl 4-{2-[7-(3-methylpiperidin-1-yl)-3-oxo-2H,3H-[1,2,4]triazolo[4,3-a]pyrimidin-2-yl]acetamido}benzoate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P573-1635

Molecular Formula

C21H24N6O4 (C21 H24 N6 O4)

Compound Name

methyl 4-{2-[7-(3-methylpiperidin-1-yl)-3-oxo-2H,3H-[1,2,4]triazolo[4,3-a]pyrimidin-2-yl]acetamido}benzoate

IUPAC name

methyl 4-{2-[7-(3-methylpiperidin-1-yl)-3-oxo-2H3H-[124]triazolo[43-a]pyrimidin-2-yl]acetamido}benzoate

SMILES

CC(CCC1)CN1C(C=CN12)=NC1=NN(CC(Nc(cc1)ccc1C(OC)=O)=O)C2=O

InChI

InChI=1S/C21H24N6O4/c1-14-4-3-10-25(12-14)17-9-11-26-20(23-17)24-27(21(26)30)13-18(28)22-16-7-5-15(6-8-16)19(29)31-2/h5-9,11,14H,3-4,10,12-13H2,1-2H3,(H,22,28)/t14-/m0/s1

InChI Key

GKWYPFCNNJQSKX-AWEZNQCLSA-N

MDL Number (MFCD)

MFCD27604727

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

424.46

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

2.229

Distribution Coefficient, logD

2.229

Water Solubility, LogSw

-2.80

Polar Surface Area

89.313

Acid Dissociation Constant (pKa)

11.55

Base Dissociation Constant (pKb)

3.45

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

38.10

P573-1635 in Drug Discovery

Included in Screening Libraries

Integrin Receptors Targeted library (1715 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

SmartTM Library (51161 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Immune system
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Others
  • Proteases

References: we are preparing a list of scientific research reports with P573-1635 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P573-1635?
Check Price and Availability of P573-1635, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P573-1635 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P573-1635
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P573-1635
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P573-1635 available by request